We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Study Finds That Xanthigen Shows Promise As Weight-Loss Supplement

January 1, 2010: 06:53 PM EST
Russian and U.S. scientists report that obese women who ingested the food supplement Xanthigen-600 (300 mg of brown marine algae-derived fucoxanthin and 300 mg of pomegranate seed oil) lost a significant amount of weight during a 16-week placebo-controlled clinical trial. Fucoxanthin is a carotenoid rich in omega-3 fatty acids. Women with non-alcoholic fatty liver disease (NAFLD) lost an average of 12 pounds, while others lost 11 pounds. The scientists also noted decreases in waist size, body fat, and liver fat. “This product may be considered a promising food supplement in the management of obesity,” the researchers conclude.
M. Abidov, Z. Ramazanov, R. Seifulla & S. Grachev, "The effects of Xanthigen™ in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat", Journal of Diabetes, Obesity and Metabolism, January 01, 2010, © Blackwell Publishing Ltd
Market News
North America
United States of America
Research, Studies, Advice
Developed by Yuri Ingultsov Software Lab.